BPIfrance and CEA Investissement both contribute cash to a series A round for the medical device company.

Medical device startup Foundry Innovation & Research, also known as Fire1, has secured $7.5m in a round backed by existing investor Medtronic.

Eye disease therapy developer GenSight Biologics, which had raised almost $78m from investors including Novartis, has withdrawn an IPO expected to raise up to $70m.

The digital health developer has now raised some $350m from investors including Novartis, Otsuka, Oracle, Medtronic, St Jude's Medical, Kaiser Permanente and ON.

Spun out of orphan drug accelerator Cydan Development, Imara will seek to develop a sickle cell disease treatment licensed from investor Lundbeck.

Vitruvian Networks has been formed by GE Ventures and Mayo Clinic to develop a gene therapy software and manufacturing platform.

Medical device startup Foundry Innovation & Research, also known as Fire1, has secured $7.5m in a round backed by existing investor Medtronic.

GV has led a $40m funding round for Quartet Health, the operator of a platform that helps users manage and understand their medical conditions.